Viewing Study NCT00096993


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-13 @ 8:03 PM
Study NCT ID: NCT00096993
Status: COMPLETED
Last Update Posted: 2015-06-10
First Post: 2004-11-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
Organization: